United States · FDA National Drug Code directory
Divalproex Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57237-048_3664094d-b13a-4476-842b-3c56298a92fd
- Product NDC
- 57237-048
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- Divalproex Sodium
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20141024
- Source listing expiry
- 20271231
Source-listed ingredients
- DIVALPROEX SODIUM — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, DELAYED RELEASE in 1 BOTTLE (57237-048-01) · 57237-048-01
- 500 TABLET, DELAYED RELEASE in 1 BOTTLE (57237-048-05) · 57237-048-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →